Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
8 Dec 2016
Neoadjuvant abemaciclib for HR positive, HER negative breast cancer
Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer
ASH 2016 highlights: breaking new ground in haematology
Pure erythroid leukaemias
Ibrutinib in CLL: RESONATE and resistance
Skull base surgery
Treatment of primary thyroid cancers
Surgery and social risk factors in Pakistan
Mindful management of microcarcinomas
Radiotherapy or surgery for oral cavity tumours?
Mutational drivers of thyroid cancer
Towards delivering truly personalised therapy for oesophageal cancer